Open AccessNonsurgical Management of Rectal CancerOpen Access
Bassel F. El-Rayes
journal of oncology practice
PublisherAmerican Society of Clinical Oncology
Neoadjuvant chemoradiotherapy followed by surgical resection is the standard of care for locally advanced rectal adenocarcinoma. Up to one third of patients achieve pathologic complete response (CR) with neoadjuvant therapy. Promising disease-free and overall survival outcomes have been reported in patients who achieve clinical CR after neoadjuvant therapy without surgical resection. Furthermore, patients who have local recurrence have acceptable disease control outcomes with salvage resection. With consideration of morbidities associated with surgical resection and similar clinical outcomes, interest in nonsurgical management of low rectal cancers has emerged. Randomized clinical trials are being conducted to evaluate a nonsurgical approach in rectal cancer. Lack of consensus on the definition of clinical CR, molecular biomarkers, and standardized nonsurgical management protocols is a significant barrier for routine clinical implementation of a nonsurgical management approach. This article aims to provide a concise review of the clinical experience and practical approach to the nonsurgical management of locoregional rectal adenocarcinoma.
Subject(s)adenocarcinoma , breast cancer , cancer , chemoradiotherapy , clinical trial , colorectal cancer , disease , general surgery , medicine , neoadjuvant therapy , radiation therapy , randomized controlled trial , surgery
SCImago Journal Rank1.555
Seeing content that should not be on Zendy? Contact us.